Completed

Phase 3
Age: 45Years - 68Years
MALE
ID00000509

Led by University of Minnesota · Updated on 2017-03-16

N/A

Participants Needed

N/A

Research Sites

N/A

Total Duration

On this page

Sponsors

U

University of Minnesota

Lead Sponsor

N

National Heart, Lung, and Blood Institute (NHLBI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

To examine the role of dietary sodium reduction with and without potassium supplementation in controlling blood pressure in hypertensive men.

CONDITIONS

Official Title

Potassium and Sodium to Control Blood Pressure in Hypertensives

Who Can Participate

Age: 45Years - 68Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

Men, ages 45 to 68. Subjects were hypertensive, were treated for at least 3.5 years with antihypertensive drugs and whose diastolic blood pressure was less than 90 mm Hg.

Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

Trial Site Locations

Site Locations not provided

Location information for this trial is currently unavailable.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

N/A

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Effect of potassium supplementation combined with dietary sodium reduction on blood pressure in men taking antihypertensive medication.

R H Grimm, P M Kofron, J D Neaton...

https://pubmed.ncbi.nlm.nih.gov/3241259